Arteris (AIP) trust plans 70,000-share NASDAQ sale after prior 10b5-1 trades

Rhea-AI Filing Summary

Atiq Raza & N. Saraiya 2012 Revocable Trust, as reported owner of AIP common stock, filed to sell 70,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $2,091,600, expected to be sold on or after August 3, 2026 on NASDAQ. The shares were acquired on December 28, 2020 via previously exercised stock options for cash. Over the past three months, the trust reported additional 10b5-1 sales of AIP common stock, including 70,000 shares for $3,176,978 on July 1, 2026, 20,839 shares for $779,174.38 on June 3, 2026, and 70,000 shares for $2,521,106 on June 1, 2026.

Key Figures

Planned shares to be sold: 70,000 shares Aggregate market value of planned sale: $2,091,600 Acquisition date of planned sale shares: 12/28/2020 +3 more

6 metrics

Planned shares to be sold 70,000 shares Common stock planned sale through Morgan Stanley Smith Barney LLC

Aggregate market value of planned sale $2,091,600 Estimated value of 70,000 AIP common shares to be sold

Acquisition date of planned sale shares 12/28/2020 Shares acquired via previously exercised stock options for cash

10b5-1 sale on July 1, 2026 70,000 shares for $3,176,978.00 Recent AIP common stock sale by the trust

10b5-1 sale on June 3, 2026 20,839 shares for $779,174.38 Recent AIP common stock sale by the trust

10b5-1 sale on June 1, 2026 70,000 shares for $2,521,106.00 Recent AIP common stock sale by the trust

Key Terms

10b5-1 sales, previously exercised stock options, aggregate market value

3 terms

10b5-1 sales regulatory

"10b5-1 Sales for S A RAZA & N SARAIYA CO-TTEES ATIQ RAZA"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

previously exercised stock options financial

"12/28/2020 | Previously Exercised Stock Options | ISSUER"

aggregate market value financial

"70000 | 2091600.00 | 46171982 | 08/03/2026 | NASDAQ"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 04:37 PM Accepted by SEC EDGAR 08/03/2026 - 04:36 PM Learn about SEC filing dates

FAQ

What stock sale is the AIP-related trust planning in this Form 144 filing?

The trust related to AIP plans to sell 70,000 shares of AIP common stock through Morgan Stanley, with an aggregate market value of $2,091,600, expected to be sold on or after August 3, 2026 on NASDAQ.

How were the 70,000 AIP shares to be sold originally acquired?

The 70,000 AIP shares covered by this planned sale were acquired on December 28, 2020 through previously exercised stock options, with the consideration paid in cash according to the disclosure.

What recent AIP stock sales has the trust reported in the last three months?

In the last three months, the trust reported 10b5-1 sales of AIP common stock including 70,000 shares for $3,176,978 on July 1, 2026, 20,839 shares for $779,174.38 on June 3, 2026, and 70,000 shares for $2,521,106 on June 1, 2026.

What trading plan is mentioned in the AIP-related stock sales disclosure?

The past three months of AIP stock sales are described as 10b5-1 sales for the S A Raza & N Saraiya co-trustees of the Atiq Raza & N Saraiya 2012 Revocable Trust, indicating use of a pre-arranged trading plan.

On which market are the planned AIP share sales expected to occur?

The filing states that the 70,000 AIP common shares are expected to be sold on the NASDAQ market on or after August 3, 2026, using Morgan Stanley Smith Barney LLC Executive Financial Services as the broker.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	70000	2091600.00	46171982	08/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/28/2020	Previously Exercised Stock Options	ISSUER			70000	12/28/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for S A RAZA & N SARAIYA CO-TTEES ATIQ RAZA & N SARAIYA 2012 REV TRU/A DTD 11/26/2012 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	07/01/2026	70000	3176978.00
10b5-1 Sales for S A RAZA & N SARAIYA CO-TTEES ATIQ RAZA & N SARAIYA 2012 REV TRU/A DTD 11/26/2012 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/03/2026	20839	779174.38
10b5-1 Sales for S A RAZA & N SARAIYA CO-TTEES ATIQ RAZA & N SARAIYA 2012 REV TRU/A DTD 11/26/2012 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	06/01/2026	70000	2521106.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)